Needham & Company Starts Aegerion Pharmaceuticals (AEGR) at Buy; Looking For Approval of Oral Orphan Cardiac Disease Treatment

Go back to Needham & Company Starts Aegerion Pharmaceuticals (AEGR) at Buy; Looking For Approval of Oral Orphan Cardiac Disease Treatment